Navigating the Diagnosis and Treatment of Extra-Adrenal Pheochromocytoma Presenting with Chronic Abdominal Pain: A Clinical Conundrum
Extra-Adrenal Pheochromocytoma with Abdominal Pain
DOI:
https://doi.org/10.61919/jhrr.v4i3.1153Keywords:
Navigating, Diagnosis, Treatment, Extra-Adrenal Pheochromocytoma, Chronic Abdominal Pain, Clinical ConundrumAbstract
Background: Extra-adrenal pheochromocytomas, or paragangliomas, are rare neuroendocrine tumors that present diagnostic challenges due to their nonspecific symptoms and radiologic features.
Objective: To report a case of extra-adrenal pheochromocytoma presenting as chronic abdominal pain and hepatic masses, emphasizing the diagnostic and therapeutic challenges.
Methods: A 36-year-old male with a history of diabetes and hypertension presented with weight loss and abdominal pain. Initial evaluation included comprehensive physical examination, laboratory tests, ultrasonography, and CT imaging of the abdomen and chest. Partial hepatectomy was performed, and the diagnosis was confirmed through histopathological and immunohistochemical analysis.
Results: Imaging identified three mixed echogenic hepatic masses, with the largest measuring 5.6 x 5.4 cm. Enlarged para-aortic lymph nodes were observed, the largest being 4.0 x 3.5 cm. CT chest revealed a mass on the chest wall (7.0 x 3.0 cm) with metastatic lung nodules. Immunohistochemistry confirmed paraganglioma with positivity for chromogranin A and neuron-specific enolase.
Conclusion: This case underscores the importance of considering paragangliomas in differential diagnoses of atypical abdominal masses and highlights the critical role of histopathological confirmation in guiding management.
Downloads
References
Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, Pacak K. Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2014;99(6):1915-1942.
Jha A, Patel S, Solanki N, Shah P. Extra-Adrenal Pheochromocytoma: A Case Report and Review of Literature. J Clin Diagn Res. 2018;12(9):1-4.
Pacak K, Eisenhofer G, Ahlman H, Bornstein SR, Gimenez-Roqueplo AP, Grossman AB, Young WF. Pheochromocytoma: Recommendations for Clinical Practice from the First International Symposium. Nat Clin Pract Endocrinol Metab. 2007;3(2):92-102.
Fishbein L, Nathanson KL. Pheochromocytoma and Paraganglioma: Understanding the Complexities of the Genetic Background. Cancer Genet. 2012;205(1-2):1-11.
Amar L, Bertherat J, Baudin E, Ajzenberg C, Bressac-de Paillerets B, Chabre O, Plouin PF. Genetic Testing in Pheochromocytoma or Functional Paraganglioma. J Clin Endocrinol Metab. 2005;90(9):881-887.
Baysal BE, Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, Bosch A, Rubinstein WS. Mutations in SDHD, a Mitochondrial Complex II Gene, in Hereditary Paraganglioma. Science. 2000;287(5454):848-851.
Neumann HP, Pawlu C, Peczkowska M, Bausch B, McWhinney SR, Muresan M, Salzmann M. Distinct Clinical Features of Paraganglioma Syndromes Associated with SDHB and SDHD Gene Mutations. JAMA. 2004;292(8):943-951.
Erickson D, Kudva YC. Etiology, Diagnosis, and Treatment of Pheochromocytoma: Emphasis on Genetics. Mayo Clin Proc. 2005;80(4):488-496.
Taieb D, Timmers HJ, Hindié E, Guillet BA, Neumann HP, Walz MK, Pacak K. EANM 2012 Guidelines for Radionuclide Imaging of Pheochromocytoma and Paraganglioma. Eur J Nucl Med Mol Imaging. 2014;41(10):1934-1946.
Crona J, Taieb D, Pacak K. New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification. Endocr Rev. 2017;38(6):489-515.
Eisenhofer G, Tischler AS, de Krijger RR. Diagnostic Procedures for Pheochromocytoma and Paraganglioma and Disease Stratification. Nat Rev Endocrinol. 2021;17:481-493.
Jha A, Patel S, Solanki N, Shah P. Extra-Adrenal Pheochromocytoma: A Case Report and Review of Literature. J Clin Diagn Res. 2018;12(9):1-4.
Young WF. Clinical Practice: Pheochromocytoma and Paraganglioma. N Engl J Med. 2019;381(6):552-565.
Muth A, Crona J, Gimm O, Elmgren A, Filipsson K, Stenmark Askmalm M, Timmers H. Genetic Testing and Surveillance Guidelines in Hereditary Pheochromocytoma and Paraganglioma. J Intern Med. 2019;285(2):187-204.
Gimenez-Roqueplo AP, Dahia PL, Robledo M. An Update on the Genetics of Paraganglioma, Pheochromocytoma, and Associated Hereditary Syndromes. Horm Metab Res. 2012;44(5):328-333.
Neumann HP, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G. Germ-Line Mutations in Nonsyndromic Pheochromocytoma. N Engl J Med. 2002;346(19):1459-1466.
Nolting S, Grossman A. Signaling Pathways in Pheochromocytomas and Paragangliomas: Prospects for Future Therapies. Endocr Pathol. 2021;32(3):218-233.
Favier J, Amar L, Gimenez-Roqueplo AP. Paraganglioma and Pheochromocytoma: From Genetics to Personalized Medicine. Nat Rev Endocrinol. 2015;11(2):101-111.
Plouin PF, Amar L, Dekkers OM, Fassnacht M, Gimenez-Roqueplo AP, Lenders JW. European Society of Endocrinology Clinical Practice Guideline for Long-Term Follow-Up of Patients Operated on for a Pheochromocytoma or a Paraganglioma. Eur J Endocrinol. 2016;174(5)
Bravo EL, Tagle R. Pheochromocytoma: State-of-the-Art and Future Prospects. Endocr Rev. 2003;24(4):539-553.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Bilal Farhat Ali, Sherien Metry, Zukhruf Fatima, Chander Khatri, Anfal Noor Rind
This work is licensed under a Creative Commons Attribution 4.0 International License.
